Mason Leeman-Markowski, MD, PHD
Clinical Neurophysiology Physician in Farmington, Connecticut.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 650 in Clinical Neurophysiology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Mason Leeman-Markowski, MD, PHD reported a CMS MIPS final score of 79.3/100 - below the 83.5 national average - and filed 574 Medicare Part D claims in 2024.
- 79.3/100
- MIPS score · -4 vs avg
- 574
- Part D claims, 2024
- 94%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Mason Leeman-Markowski, MD, PHD
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1962666545), first enumerated 07/14/2008.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 574 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 79.3/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
2 CMS Care Compare hospital affiliations on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1962666545 · Clinical Neurophysiology Physician
NPI-10 · ENUM-MID · TAX-NARROW · MIPS-BELOW · RX-LIGHT · BOOK-THIN · PHOTO-FINISH
- NPI-10 1962666545
- ENUM-MID 2008
- TAX-NARROW 650
- MIPS-BELOW 79.3/100
- RX-LIGHT 574
- BOOK-THIN 14 in Connecticut
- PHOTO-FINISH Muhammad Al-Lozi, MD · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Enrico Vintayen,…
Enrico Vintayen, MD
78.8 MIPS pts
- Leeman-Markowski…
Leeman-Markowski · this provider
79.3 MIPS pts
- Muhammad Al-Lozi…
Muhammad Al-Lozi, MD
79.3 MIPS pts
- Gloria Galloway,…
Gloria Galloway, MD
79.4 MIPS pts
- Naiara Garcia Lo…
Naiara Garcia Losarcos, M.D.
79.5 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Mason Leeman-Markowski, MD, PHD's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
79 ≥ 26th percentile 26% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Mason Leeman-Markowski, MD, PHD sits
This provider among clinical neurophysiology physician peers
Across the 176 clinical neurophysiology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Mason Leeman-Markowski, MD, PHD writes more Part D claims than 34% of them and scores higher on MIPS quality than 30% - placing this provider in the lower-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one clinical neurophysiology physician peer from a representative sample of 60; the gold marker is Mason Leeman-Markowski, MD, PHD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Mason Leeman-Markowski, MD, PHD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Mason Leeman-Markowski, MD, PHD?
Near national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Connecticut
How Clinical Neurophysiology Physician compares to other specialties among Connecticut providers
Clinical Neurophysiology Physician ranks #232 among Connecticut's specialties (0% of in-state providers)
Each bar is a specialty's share of the Connecticut provider total, by primary NUCC taxonomy. The highlighted bar is Clinical Neurophysiology Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Mason Leeman-Markowski, MD, PHD's 2023 MIPS final score plotted against the Clinical Neurophysiology Physician national average
- MIPS Final Score
- 79.3/100
- vs 83.5 national avg · 2023 performance year
Quality benchmarks
- National MIPS avg 2023 measured reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Clinical Neurophysiology Physician US NPIs
79.3/100 MIPS final score - 4.2 pts below the 83.5 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Clinical Neurophysiology Physician. Quality dim: 69.2. Cost dim: 48.1.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1962666545 |
|---|---|
| Specialty | Clinical Neurophysiology Physician |
| Credentials | MD, PHD |
| Gender | Male |
| NPI Issued | 07/14/2008 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Mason Leeman-Markowski, MD, PHD's current license status, disciplinary history, and board certifications with the Connecticut Department of Public Health in Connecticut before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1962666545 is the unique 10-digit identifier CMS uses to link Leeman-Markowski across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where Mason Leeman-Markowski, MD, PHD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Brand vs generic prescribing mix · Generic-heavy
6% brand-name claims vs 94% generic, on 574 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
Prescribing Breakdown
- 30-Day Fills
- 1,147.067
- Total Day Supply
- 33,502
- Brand vs Generic
- 6% brand / 94% generic
- Brand Drug Cost
- $33K
- Generic Drug Cost
- $29K
Patient Demographics
- Average Patient Age
- 67.4 years
- Avg HCC Risk Score
- 1.65
- Gender Split
- 55% female / 45% male
- Age Distribution
- <65: 38, 65-74: 42, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Mason Leeman-Markowski, MD, PHD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Levetiracetam
Levetiracetam
123 claims
- Atorvastatin Calcium
Atorvastatin Calcium
56 claims
- Lacosamide
Lacosamide
56 claims
- Topiramate 36
Topiramate
36 claims
- Eliquis 28
Eliquis
28 claims
- Divalproex Sodium Er 27
Divalproex Sodium Er
27 claims
- Clopidogrel 26
Clopidogrel
26 claims
- Gabapentin 23
Gabapentin
23 claims
| Drug | Claims |
|---|---|
| Levetiracetam | 123 |
| Atorvastatin Calcium | 56 |
| Lacosamide | 56 |
| Topiramate | 36 |
| Eliquis Apixaban | 28 |
| Divalproex Sodium Er Divalproex Sodium | 27 |
| Clopidogrel Clopidogrel Bisulfate | 26 |
| Gabapentin | 23 |
| Clobazam | 22 |
| Lamotrigine | 19 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Clinical Neurophysiology Physician Overview
How Mason Leeman-Markowski, MD, PHD fits within the Clinical Neurophysiology Physician landscape nationally.
Mason Leeman-Markowski, MD, PHD's 574 claims are below the specialty average of 1,582.
Nationwide Clinical Neurophysiology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Leeman-Markowski, both outside Connecticut so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (79.3 here).
Same NPPES enumeration year (2008)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Clinical Neurophysiology Physician Providers in Connecticut
Other clinicians with the same primary specialty enrolled in Connecticut, drawn from the same CMS NPPES roster as Leeman-Markowski.
One of 14 Clinical Neurophysiology Physician providers enrolled in Connecticut, 5 are shown here.
Compare Clinical Neurophysiology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Mason Leeman-Markowski, MD, PHD's specialty? ▼
How much does Mason Leeman-Markowski, MD, PHD prescribe under Medicare Part D? ▼
What is Mason Leeman-Markowski, MD, PHD's Medicare quality score? ▼
Where is Mason Leeman-Markowski, MD, PHD located? ▼
What is Mason Leeman-Markowski, MD, PHD's NPI number? ▼
Does Mason Leeman-Markowski, MD, PHD prescribe more brand-name or generic drugs? ▼
How many Clinical Neurophysiology Physician providers are there in the US? ▼
What drugs does Mason Leeman-Markowski, MD, PHD prescribe most often? ▼
Does Mason Leeman-Markowski, MD, PHD accept Medicare? ▼
How can I verify Mason Leeman-Markowski, MD, PHD's credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.
Published by
PlainDoctor
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.